Home
VRTX
VRTX News

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on April 2, 2025

MT Newswires

17 hours ago

RBC Adjusts Price Target on Vertex Pharmaceuticals to $420 From $408, Maintains Sector Perform Rating

These biotech names aren't facing 'huge concern' from tariffs

Yahoo Finance Video

19 hours ago

These biotech names aren't facing 'huge concern' from tariffs

Intellia Focuses on Pipeline Development Amid Stiff Competition

Zacks

2 days ago

Intellia Focuses on Pipeline Development Amid Stiff Competition

Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”

Insider Monkey

2 days ago

Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”

Vertex halts development of diabetes cell therapy after trial failure

Pharmaceutical Technology

2 days ago

Vertex halts development of diabetes cell therapy after trial failure

MT Newswires

2 days ago

Vertex Pharmaceuticals Ends VX-264 Study in Diabetes After Failing to Meet Efficacy Endpoint

Vertex Pharmaceuticals (NasdaqGS:VRTX) Advances Diabetes Portfolio Despite 2% Decline in Share Price

Simply Wall St.

4 days ago

Vertex Pharmaceuticals (NasdaqGS:VRTX) Advances Diabetes Portfolio Despite 2% Decline in Share Price

Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?

Insider Monkey

4 days ago

Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?

Vertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should Know

Zacks

4 days ago

Vertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should Know

Vertex Announces Program Updates for Type 1 Diabetes Portfolio

Business Wire

4 days ago

Vertex Announces Program Updates for Type 1 Diabetes Portfolio

Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession

Motley Fool

5 days ago

Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession

Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors

Zacks

5 days ago

Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.

Barrons.com

6 days ago

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Zacks

7 days ago

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

MT Newswires

9 days ago

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $512 From $500, Keeps Overweight Rating

Jim Cramer on Vertex (VRTX): “A Revolutionary Anti-Pain Drug”

Insider Monkey

10 days ago

Jim Cramer on Vertex (VRTX): “A Revolutionary Anti-Pain Drug”

2 Beaten-Down Stocks to Buy on the Dip

Motley Fool

10 days ago

2 Beaten-Down Stocks to Buy on the Dip

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks

11 days ago

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue?

Zacks

12 days ago

Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue?

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

Investor's Business Daily

12 days ago

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

StockStory

13 days ago

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

Vertex Pharmaceuticals (VRTX) Rises But Trails Market: What Investors Should Know

Zacks

13 days ago

Vertex Pharmaceuticals (VRTX) Rises But Trails Market: What Investors Should Know

Is Vertex Pharmaceuticals (VRTX) the Best Diabetes Stock to Buy According to Billionaires?

Insider Monkey

14 days ago

Is Vertex Pharmaceuticals (VRTX) the Best Diabetes Stock to Buy According to Billionaires?

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

Motley Fool

14 days ago

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

Insider Monkey

14 days ago

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

StockStory

14 days ago

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

Vertex Pharmaceuticals (VRTX): One of the Best Biotech Stocks to Buy According to Billionaires

Insider Monkey

15 days ago

Vertex Pharmaceuticals (VRTX): One of the Best Biotech Stocks to Buy According to Billionaires

Is Vertex Pharmaceuticals (VRTX) Among the Best High Growth Stocks?

Insider Monkey

15 days ago

Is Vertex Pharmaceuticals (VRTX) Among the Best High Growth Stocks?

Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?

Zacks

16 days ago

Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?

3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Motley Fool

16 days ago

3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report?

Zacks

19 days ago

Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report?

3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

Motley Fool

19 days ago

3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today

Zacks

19 days ago

Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today

GILD vs. VRTX: Which Stock Is the Better Value Option?

Zacks

20 days ago

GILD vs. VRTX: Which Stock Is the Better Value Option?

Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know

Zacks

20 days ago

Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know

MT Newswires

20 days ago

Vertex Pharmaceuticals Insider Sold Shares Worth $1,620,968, According to a Recent SEC Filing

MT Newswires

20 days ago

Vertex Pharmaceuticals Insider Sold Shares Worth $1,649,000, According to a Recent SEC Filing

Why Vertex Pharmaceuticals Incorporated (VRTX) is the Best Pharma Stock to Buy According to Hedge Funds

Insider Monkey

20 days ago

Why Vertex Pharmaceuticals Incorporated (VRTX) is the Best Pharma Stock to Buy According to Hedge Funds

Why Is Vertex (VRTX) Up 7.3% Since Last Earnings Report?

Zacks

21 days ago

Why Is Vertex (VRTX) Up 7.3% Since Last Earnings Report?

Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?

Insider Monkey

21 days ago

Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?

Company News for Mar 11, 2025

Zacks

22 days ago

Company News for Mar 11, 2025

Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever

Motley Fool

22 days ago

Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever

3 Reasons to Avoid VRTX and 1 Stock to Buy Instead

StockStory

22 days ago

3 Reasons to Avoid VRTX and 1 Stock to Buy Instead

Where Will Vertex Pharmaceuticals Be in 10 Years?

Motley Fool

22 days ago

Where Will Vertex Pharmaceuticals Be in 10 Years?

If I Could Buy Only 1 Growth Stock, This Would Be It

Motley Fool

23 days ago

If I Could Buy Only 1 Growth Stock, This Would Be It

3 Magnificent Growth Stocks to Buy in March

Motley Fool

25 days ago

3 Magnificent Growth Stocks to Buy in March

Vertex Pharmaceuticals (NasdaqGS:VRTX) Gains UK Approval For New Cystic Fibrosis Treatment

Simply Wall St.

a month ago

Vertex Pharmaceuticals (NasdaqGS:VRTX) Gains UK Approval For New Cystic Fibrosis Treatment

MT Newswires

a month ago

Update: Vertex Pharmaceuticals Says Journavx Non-Opioid Pain Killer Added to Optum Formulary

MT Newswires

a month ago

Vertex Pharmaceuticals Gets UK Regulatory Approval for Alyftrek to Treat Cystic Fibrosis

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Business Wire

a month ago

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

MT Newswires

a month ago

Vertex Pharmaceuticals Says Journavx Non-Opioid Pain Killer Added to Optum Formulary

Vertex Pharmaceuticals Leads 3 Value Stocks Offering Estimated Intrinsic Value

Simply Wall St.

a month ago

Vertex Pharmaceuticals Leads 3 Value Stocks Offering Estimated Intrinsic Value

5 Top Stocks to Buy in March

Motley Fool

a month ago

5 Top Stocks to Buy in March

MT Newswires

a month ago

Vertex Pharmaceuticals Insider Sold Shares Worth $251,930, According to a Recent SEC Filing

MT Newswires

a month ago

Vertex Pharmaceuticals Insider Sold Shares Worth $1,259,651, According to a Recent SEC Filing

MT Newswires

a month ago

Vertex Pharmaceuticals Insider Sold Shares Worth $610,560, According to a Recent SEC Filing

Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations

Business Wire

a month ago

Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations

Argus Research

a month ago

Analyst Report: Vertex Pharmaceuticals, Inc.

Argus Research

a month ago

Market Digest: ICE, NOC, VRTX, UL, ZM

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market

Pharmaceutical Technology

a month ago

Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market

Vertex's FDA Win: A Billion-Dollar Bet on Safer Pain Treatment

GuruFocus.com

a month ago

Vertex's FDA Win: A Billion-Dollar Bet on Safer Pain Treatment

High Growth Tech Stocks To Watch In February 2025

Simply Wall St.

a month ago

High Growth Tech Stocks To Watch In February 2025

Vertex Pharmaceuticals Incorporated (VRTX): Among Renaissance Technologies Portfolio’s Top Stock Picks

Insider Monkey

a month ago

Vertex Pharmaceuticals Incorporated (VRTX): Among Renaissance Technologies Portfolio’s Top Stock Picks

3 Magnificent Growth Stocks to Buy Right Now

Motley Fool

a month ago

3 Magnificent Growth Stocks to Buy Right Now

2 No-Brainer Healthcare Stocks to Buy With $500 Right Now

Motley Fool

a month ago

2 No-Brainer Healthcare Stocks to Buy With $500 Right Now

GILD or VRTX: Which Is the Better Value Stock Right Now?

Zacks

a month ago

GILD or VRTX: Which Is the Better Value Stock Right Now?

MT Newswires

a month ago

RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $408 From $407, Maintains Sector Perform Rating

Vertex to Participate in Upcoming March Investor Conferences

Business Wire

a month ago

Vertex to Participate in Upcoming March Investor Conferences

3 Stocks That Could Trounce the Market in 2025

Motley Fool

a month ago

3 Stocks That Could Trounce the Market in 2025

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

Motley Fool

2 months ago

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

GuruFocus.com

2 months ago

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

The Ultimate Healthcare Stock to Buy With $500 Right Now

Motley Fool

2 months ago

The Ultimate Healthcare Stock to Buy With $500 Right Now

Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing

Motley Fool

2 months ago

Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing

MT Newswires

2 months ago

Vertex Pharmaceuticals Insider Sold Shares Worth $632,726, According to a Recent SEC Filing

Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank

TipRanks

2 months ago

Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank

Vertex Pharmaceuticals price target raised to $520 from $460 at Truist

TipRanks

2 months ago

Vertex Pharmaceuticals price target raised to $520 from $460 at Truist

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

Zacks

2 months ago

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

MT Newswires

2 months ago

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $500 From $501, Maintains Overweight Rating

MT Newswires

2 months ago

Redburn Atlantic Adjusts Price Target on Vertex Pharmaceuticals to $560 From $550, Maintains Buy Rating

MT Newswires

2 months ago

Daiwa Adjusts Price Target on Vertex Pharmaceuticals to $530 From $550, Maintains Buy Rating

MT Newswires

2 months ago

Canaccord Genuity Upgrades Vertex Pharmaceuticals to Hold From Sell, Adjusts Price Target to $424 From $408

Morningstar Research

2 months ago

Analyst Report: Vertex Pharmaceuticals Incorporated

Vertex Posts 'Another Impressive Quarterly Revenue Beat.' But The Future Remains Uncertain.

Investor's Business Daily

2 months ago

Vertex Posts 'Another Impressive Quarterly Revenue Beat.' But The Future Remains Uncertain.

Vertex: Strong Sales, Stronger Pipeline

Motley Fool

2 months ago

Vertex: Strong Sales, Stronger Pipeline

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Vertex Pharmaceuticals Inc Earnings Call

MT Newswires

2 months ago

RBC Raises Price Target on Vertex Pharmaceuticals to $407 From $402, Keeps Sector Perform Rating

MT Newswires

2 months ago

Scotiabank Adjusts Price Target on Vertex Pharmaceuticals to $450 From $433, Maintains Sector Perform Rating

MT Newswires

2 months ago

Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $459 From $450, Maintains Equalweight Rating

MT Newswires

2 months ago

Truist Adjusts Price Target on Vertex Pharmaceuticals to $520 From $460, Maintains Buy Rating

MT Newswires

2 months ago

Leerink Partners Adjusts Price Target on Vertex Pharmaceuticals to $550 From $542, Maintains Outperform Rating

Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Intrinsic Value Is Potentially 50% Above Its Share Price

Simply Wall St.

2 months ago

Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Intrinsic Value Is Potentially 50% Above Its Share Price

Argus Research

2 months ago

Weekly Stock List

2 Biotech Stocks to Buy Hand Over Fist in February

Motley Fool

2 months ago

2 Biotech Stocks to Buy Hand Over Fist in February

Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For

StockStory

2 months ago

Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For

What To Expect in the Markets This Week

Investopedia

2 months ago

What To Expect in the Markets This Week

MT Newswires

2 months ago

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $501 From $500

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Zacks

2 months ago

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Is VRTX a Portfolio Must Have After Two FDA Nods Ahead of Q4 Earnings?

Zacks

2 months ago

Is VRTX a Portfolio Must Have After Two FDA Nods Ahead of Q4 Earnings?

Share on Social Networks: